TobinEHTristramD.Tuberculosis overview. Treasure Island, FL: StatPearls, 2024.
2.
ThursbyEJugeN.Introduction to the human gut microbiota. Biochem J2017; 474(11): 1823–1836.
3.
Alvarado-PenaNGaleana-CadenaDGomez-GarciaIA, et al. The microbiome and the gut–lung axis in tuberculosis: interplay in the course of disease and treatment. Front Microbiol2023; 14: 1237998.
4.
CervantesJHongB.The gut–lung axis in tuberculosis. Pathog Dis2017; 75(8): ftx097.
5.
ChaiYLiuXBaiG, et al. Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis. Front Immunol2024; 15: 1323723.
6.
HuYYangQLiuB, et al. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J Infect2019; 78(4): 317–322.
7.
WippermanMFFitzgeraldDWJusteMAJ, et al. Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci Rep2017; 7(1): 10767.
8.
DangATMarslandBJ.Microbes, metabolites, and the gut–lung axis. Mucosal Immunol2019; 12(4): 843–850.
9.
HirayamaMNishiwakiHHamaguchiT, et al. Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate. PLoS One2021; 16(11): e0260451.
10.
WangMZhangYLiC, et al. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Front Immunol2023; 14: 1180336.
